Global Oxaprozin Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Oxaprozin (Actirin) is a drug used for the treatment of rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, ankylosis, cervical, shoulder and wrist syndrome, periarthritis of the shoulder, gout, and after trauma and surgery anti-inflammatory analgesia.
LPI (LP Information)' newest research report, the “Oxaprozin Industry Forecast” looks at past sales and reviews total world Oxaprozin sales in 2022, providing a comprehensive analysis by region and market sector of projected Oxaprozin sales for 2023 through 2029. With Oxaprozin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oxaprozin industry.
This Insight Report provides a comprehensive analysis of the global Oxaprozin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oxaprozin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oxaprozin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oxaprozin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oxaprozin.
The global Oxaprozin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oxaprozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oxaprozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oxaprozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oxaprozin players cover Pfizer, Helsinn, Taisho, Ildong, PD-Rx Pharmaceuticals, Therapicon, Neolpharma, Apotex Corporation and Yichang Dongyangguang Changjiang Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oxaprozin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Oxaprozin market?
What factors are driving Oxaprozin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oxaprozin market opportunities vary by end market size?
How does Oxaprozin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Oxaprozin (Actirin) is a drug used for the treatment of rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, ankylosis, cervical, shoulder and wrist syndrome, periarthritis of the shoulder, gout, and after trauma and surgery anti-inflammatory analgesia.
LPI (LP Information)' newest research report, the “Oxaprozin Industry Forecast” looks at past sales and reviews total world Oxaprozin sales in 2022, providing a comprehensive analysis by region and market sector of projected Oxaprozin sales for 2023 through 2029. With Oxaprozin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oxaprozin industry.
This Insight Report provides a comprehensive analysis of the global Oxaprozin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oxaprozin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oxaprozin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oxaprozin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oxaprozin.
The global Oxaprozin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oxaprozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oxaprozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oxaprozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oxaprozin players cover Pfizer, Helsinn, Taisho, Ildong, PD-Rx Pharmaceuticals, Therapicon, Neolpharma, Apotex Corporation and Yichang Dongyangguang Changjiang Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oxaprozin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Tablets
- Capsule
- Rheumatoid Arthritis
- Chronic Infectious Arthritis
- Osteoarthritis
- Ankylosing Spondylitis
- Neck Shoulder Wrist Syndrome
- Periarthritis Of Shoulder
- Gout
- Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Helsinn
- Taisho
- Ildong
- PD-Rx Pharmaceuticals
- Therapicon
- Neolpharma
- Apotex Corporation
- Yichang Dongyangguang Changjiang Pharmaceutical
- Hubei Baike Hengdi Pharmaceutical
- Fuan Pharmaceutical Group
- Hubei Baike Hengdi Pharmaceutical
- Pfizer
What is the 10-year outlook for the global Oxaprozin market?
What factors are driving Oxaprozin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oxaprozin market opportunities vary by end market size?
How does Oxaprozin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oxaprozin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oxaprozin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oxaprozin by Country/Region, 2018, 2022 & 2029
2.2 Oxaprozin Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.3 Oxaprozin Sales by Type
2.3.1 Global Oxaprozin Sales Market Share by Type (2018-2023)
2.3.2 Global Oxaprozin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oxaprozin Sale Price by Type (2018-2023)
2.4 Oxaprozin Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Chronic Infectious Arthritis
2.4.3 Osteoarthritis
2.4.4 Ankylosing Spondylitis
2.4.5 Neck Shoulder Wrist Syndrome
2.4.6 Periarthritis Of Shoulder
2.4.7 Gout
2.4.8 Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
2.4.9 Other
2.5 Oxaprozin Sales by Application
2.5.1 Global Oxaprozin Sale Market Share by Application (2018-2023)
2.5.2 Global Oxaprozin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oxaprozin Sale Price by Application (2018-2023)
3 GLOBAL OXAPROZIN BY COMPANY
3.1 Global Oxaprozin Breakdown Data by Company
3.1.1 Global Oxaprozin Annual Sales by Company (2018-2023)
3.1.2 Global Oxaprozin Sales Market Share by Company (2018-2023)
3.2 Global Oxaprozin Annual Revenue by Company (2018-2023)
3.2.1 Global Oxaprozin Revenue by Company (2018-2023)
3.2.2 Global Oxaprozin Revenue Market Share by Company (2018-2023)
3.3 Global Oxaprozin Sale Price by Company
3.4 Key Manufacturers Oxaprozin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oxaprozin Product Location Distribution
3.4.2 Players Oxaprozin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OXAPROZIN BY GEOGRAPHIC REGION
4.1 World Historic Oxaprozin Market Size by Geographic Region (2018-2023)
4.1.1 Global Oxaprozin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oxaprozin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oxaprozin Market Size by Country/Region (2018-2023)
4.2.1 Global Oxaprozin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oxaprozin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oxaprozin Sales Growth
4.4 APAC Oxaprozin Sales Growth
4.5 Europe Oxaprozin Sales Growth
4.6 Middle East & Africa Oxaprozin Sales Growth
5 AMERICAS
5.1 Americas Oxaprozin Sales by Country
5.1.1 Americas Oxaprozin Sales by Country (2018-2023)
5.1.2 Americas Oxaprozin Revenue by Country (2018-2023)
5.2 Americas Oxaprozin Sales by Type
5.3 Americas Oxaprozin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oxaprozin Sales by Region
6.1.1 APAC Oxaprozin Sales by Region (2018-2023)
6.1.2 APAC Oxaprozin Revenue by Region (2018-2023)
6.2 APAC Oxaprozin Sales by Type
6.3 APAC Oxaprozin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oxaprozin by Country
7.1.1 Europe Oxaprozin Sales by Country (2018-2023)
7.1.2 Europe Oxaprozin Revenue by Country (2018-2023)
7.2 Europe Oxaprozin Sales by Type
7.3 Europe Oxaprozin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oxaprozin by Country
8.1.1 Middle East & Africa Oxaprozin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oxaprozin Revenue by Country (2018-2023)
8.2 Middle East & Africa Oxaprozin Sales by Type
8.3 Middle East & Africa Oxaprozin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oxaprozin
10.3 Manufacturing Process Analysis of Oxaprozin
10.4 Industry Chain Structure of Oxaprozin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oxaprozin Distributors
11.3 Oxaprozin Customer
12 WORLD FORECAST REVIEW FOR OXAPROZIN BY GEOGRAPHIC REGION
12.1 Global Oxaprozin Market Size Forecast by Region
12.1.1 Global Oxaprozin Forecast by Region (2024-2029)
12.1.2 Global Oxaprozin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oxaprozin Forecast by Type
12.7 Global Oxaprozin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Oxaprozin Product Portfolios and Specifications
13.1.3 Pfizer Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Helsinn
13.2.1 Helsinn Company Information
13.2.2 Helsinn Oxaprozin Product Portfolios and Specifications
13.2.3 Helsinn Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Helsinn Main Business Overview
13.2.5 Helsinn Latest Developments
13.3 Taisho
13.3.1 Taisho Company Information
13.3.2 Taisho Oxaprozin Product Portfolios and Specifications
13.3.3 Taisho Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Taisho Main Business Overview
13.3.5 Taisho Latest Developments
13.4 Ildong
13.4.1 Ildong Company Information
13.4.2 Ildong Oxaprozin Product Portfolios and Specifications
13.4.3 Ildong Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ildong Main Business Overview
13.4.5 Ildong Latest Developments
13.5 PD-Rx Pharmaceuticals
13.5.1 PD-Rx Pharmaceuticals Company Information
13.5.2 PD-Rx Pharmaceuticals Oxaprozin Product Portfolios and Specifications
13.5.3 PD-Rx Pharmaceuticals Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 PD-Rx Pharmaceuticals Main Business Overview
13.5.5 PD-Rx Pharmaceuticals Latest Developments
13.6 Therapicon
13.6.1 Therapicon Company Information
13.6.2 Therapicon Oxaprozin Product Portfolios and Specifications
13.6.3 Therapicon Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Therapicon Main Business Overview
13.6.5 Therapicon Latest Developments
13.7 Neolpharma
13.7.1 Neolpharma Company Information
13.7.2 Neolpharma Oxaprozin Product Portfolios and Specifications
13.7.3 Neolpharma Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Neolpharma Main Business Overview
13.7.5 Neolpharma Latest Developments
13.8 Apotex Corporation
13.8.1 Apotex Corporation Company Information
13.8.2 Apotex Corporation Oxaprozin Product Portfolios and Specifications
13.8.3 Apotex Corporation Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Apotex Corporation Main Business Overview
13.8.5 Apotex Corporation Latest Developments
13.9 Yichang Dongyangguang Changjiang Pharmaceutical
13.9.1 Yichang Dongyangguang Changjiang Pharmaceutical Company Information
13.9.2 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product Portfolios and Specifications
13.9.3 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Yichang Dongyangguang Changjiang Pharmaceutical Main Business Overview
13.9.5 Yichang Dongyangguang Changjiang Pharmaceutical Latest Developments
13.10 Hubei Baike Hengdi Pharmaceutical
13.10.1 Hubei Baike Hengdi Pharmaceutical Company Information
13.10.2 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolios and Specifications
13.10.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hubei Baike Hengdi Pharmaceutical Main Business Overview
13.10.5 Hubei Baike Hengdi Pharmaceutical Latest Developments
13.11 Fuan Pharmaceutical Group
13.11.1 Fuan Pharmaceutical Group Company Information
13.11.2 Fuan Pharmaceutical Group Oxaprozin Product Portfolios and Specifications
13.11.3 Fuan Pharmaceutical Group Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Fuan Pharmaceutical Group Main Business Overview
13.11.5 Fuan Pharmaceutical Group Latest Developments
13.12 Hubei Baike Hengdi Pharmaceutical
13.12.1 Hubei Baike Hengdi Pharmaceutical Company Information
13.12.2 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolios and Specifications
13.12.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hubei Baike Hengdi Pharmaceutical Main Business Overview
13.12.5 Hubei Baike Hengdi Pharmaceutical Latest Developments
13.13 Pfizer
13.13.1 Pfizer Company Information
13.13.2 Pfizer Oxaprozin Product Portfolios and Specifications
13.13.3 Pfizer Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Pfizer Main Business Overview
13.13.5 Pfizer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oxaprozin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oxaprozin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oxaprozin by Country/Region, 2018, 2022 & 2029
2.2 Oxaprozin Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.3 Oxaprozin Sales by Type
2.3.1 Global Oxaprozin Sales Market Share by Type (2018-2023)
2.3.2 Global Oxaprozin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oxaprozin Sale Price by Type (2018-2023)
2.4 Oxaprozin Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Chronic Infectious Arthritis
2.4.3 Osteoarthritis
2.4.4 Ankylosing Spondylitis
2.4.5 Neck Shoulder Wrist Syndrome
2.4.6 Periarthritis Of Shoulder
2.4.7 Gout
2.4.8 Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
2.4.9 Other
2.5 Oxaprozin Sales by Application
2.5.1 Global Oxaprozin Sale Market Share by Application (2018-2023)
2.5.2 Global Oxaprozin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oxaprozin Sale Price by Application (2018-2023)
3 GLOBAL OXAPROZIN BY COMPANY
3.1 Global Oxaprozin Breakdown Data by Company
3.1.1 Global Oxaprozin Annual Sales by Company (2018-2023)
3.1.2 Global Oxaprozin Sales Market Share by Company (2018-2023)
3.2 Global Oxaprozin Annual Revenue by Company (2018-2023)
3.2.1 Global Oxaprozin Revenue by Company (2018-2023)
3.2.2 Global Oxaprozin Revenue Market Share by Company (2018-2023)
3.3 Global Oxaprozin Sale Price by Company
3.4 Key Manufacturers Oxaprozin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oxaprozin Product Location Distribution
3.4.2 Players Oxaprozin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OXAPROZIN BY GEOGRAPHIC REGION
4.1 World Historic Oxaprozin Market Size by Geographic Region (2018-2023)
4.1.1 Global Oxaprozin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oxaprozin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oxaprozin Market Size by Country/Region (2018-2023)
4.2.1 Global Oxaprozin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oxaprozin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oxaprozin Sales Growth
4.4 APAC Oxaprozin Sales Growth
4.5 Europe Oxaprozin Sales Growth
4.6 Middle East & Africa Oxaprozin Sales Growth
5 AMERICAS
5.1 Americas Oxaprozin Sales by Country
5.1.1 Americas Oxaprozin Sales by Country (2018-2023)
5.1.2 Americas Oxaprozin Revenue by Country (2018-2023)
5.2 Americas Oxaprozin Sales by Type
5.3 Americas Oxaprozin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oxaprozin Sales by Region
6.1.1 APAC Oxaprozin Sales by Region (2018-2023)
6.1.2 APAC Oxaprozin Revenue by Region (2018-2023)
6.2 APAC Oxaprozin Sales by Type
6.3 APAC Oxaprozin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oxaprozin by Country
7.1.1 Europe Oxaprozin Sales by Country (2018-2023)
7.1.2 Europe Oxaprozin Revenue by Country (2018-2023)
7.2 Europe Oxaprozin Sales by Type
7.3 Europe Oxaprozin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oxaprozin by Country
8.1.1 Middle East & Africa Oxaprozin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oxaprozin Revenue by Country (2018-2023)
8.2 Middle East & Africa Oxaprozin Sales by Type
8.3 Middle East & Africa Oxaprozin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oxaprozin
10.3 Manufacturing Process Analysis of Oxaprozin
10.4 Industry Chain Structure of Oxaprozin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oxaprozin Distributors
11.3 Oxaprozin Customer
12 WORLD FORECAST REVIEW FOR OXAPROZIN BY GEOGRAPHIC REGION
12.1 Global Oxaprozin Market Size Forecast by Region
12.1.1 Global Oxaprozin Forecast by Region (2024-2029)
12.1.2 Global Oxaprozin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oxaprozin Forecast by Type
12.7 Global Oxaprozin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Oxaprozin Product Portfolios and Specifications
13.1.3 Pfizer Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Helsinn
13.2.1 Helsinn Company Information
13.2.2 Helsinn Oxaprozin Product Portfolios and Specifications
13.2.3 Helsinn Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Helsinn Main Business Overview
13.2.5 Helsinn Latest Developments
13.3 Taisho
13.3.1 Taisho Company Information
13.3.2 Taisho Oxaprozin Product Portfolios and Specifications
13.3.3 Taisho Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Taisho Main Business Overview
13.3.5 Taisho Latest Developments
13.4 Ildong
13.4.1 Ildong Company Information
13.4.2 Ildong Oxaprozin Product Portfolios and Specifications
13.4.3 Ildong Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ildong Main Business Overview
13.4.5 Ildong Latest Developments
13.5 PD-Rx Pharmaceuticals
13.5.1 PD-Rx Pharmaceuticals Company Information
13.5.2 PD-Rx Pharmaceuticals Oxaprozin Product Portfolios and Specifications
13.5.3 PD-Rx Pharmaceuticals Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 PD-Rx Pharmaceuticals Main Business Overview
13.5.5 PD-Rx Pharmaceuticals Latest Developments
13.6 Therapicon
13.6.1 Therapicon Company Information
13.6.2 Therapicon Oxaprozin Product Portfolios and Specifications
13.6.3 Therapicon Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Therapicon Main Business Overview
13.6.5 Therapicon Latest Developments
13.7 Neolpharma
13.7.1 Neolpharma Company Information
13.7.2 Neolpharma Oxaprozin Product Portfolios and Specifications
13.7.3 Neolpharma Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Neolpharma Main Business Overview
13.7.5 Neolpharma Latest Developments
13.8 Apotex Corporation
13.8.1 Apotex Corporation Company Information
13.8.2 Apotex Corporation Oxaprozin Product Portfolios and Specifications
13.8.3 Apotex Corporation Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Apotex Corporation Main Business Overview
13.8.5 Apotex Corporation Latest Developments
13.9 Yichang Dongyangguang Changjiang Pharmaceutical
13.9.1 Yichang Dongyangguang Changjiang Pharmaceutical Company Information
13.9.2 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product Portfolios and Specifications
13.9.3 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Yichang Dongyangguang Changjiang Pharmaceutical Main Business Overview
13.9.5 Yichang Dongyangguang Changjiang Pharmaceutical Latest Developments
13.10 Hubei Baike Hengdi Pharmaceutical
13.10.1 Hubei Baike Hengdi Pharmaceutical Company Information
13.10.2 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolios and Specifications
13.10.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hubei Baike Hengdi Pharmaceutical Main Business Overview
13.10.5 Hubei Baike Hengdi Pharmaceutical Latest Developments
13.11 Fuan Pharmaceutical Group
13.11.1 Fuan Pharmaceutical Group Company Information
13.11.2 Fuan Pharmaceutical Group Oxaprozin Product Portfolios and Specifications
13.11.3 Fuan Pharmaceutical Group Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Fuan Pharmaceutical Group Main Business Overview
13.11.5 Fuan Pharmaceutical Group Latest Developments
13.12 Hubei Baike Hengdi Pharmaceutical
13.12.1 Hubei Baike Hengdi Pharmaceutical Company Information
13.12.2 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolios and Specifications
13.12.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hubei Baike Hengdi Pharmaceutical Main Business Overview
13.12.5 Hubei Baike Hengdi Pharmaceutical Latest Developments
13.13 Pfizer
13.13.1 Pfizer Company Information
13.13.2 Pfizer Oxaprozin Product Portfolios and Specifications
13.13.3 Pfizer Oxaprozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Pfizer Main Business Overview
13.13.5 Pfizer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oxaprozin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oxaprozin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsule
Table 5. Global Oxaprozin Sales by Type (2018-2023) & (KG)
Table 6. Global Oxaprozin Sales Market Share by Type (2018-2023)
Table 7. Global Oxaprozin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Oxaprozin Revenue Market Share by Type (2018-2023)
Table 9. Global Oxaprozin Sale Price by Type (2018-2023) & (US$/G)
Table 10. Global Oxaprozin Sales by Application (2018-2023) & (KG)
Table 11. Global Oxaprozin Sales Market Share by Application (2018-2023)
Table 12. Global Oxaprozin Revenue by Application (2018-2023)
Table 13. Global Oxaprozin Revenue Market Share by Application (2018-2023)
Table 14. Global Oxaprozin Sale Price by Application (2018-2023) & (US$/G)
Table 15. Global Oxaprozin Sales by Company (2018-2023) & (KG)
Table 16. Global Oxaprozin Sales Market Share by Company (2018-2023)
Table 17. Global Oxaprozin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Oxaprozin Revenue Market Share by Company (2018-2023)
Table 19. Global Oxaprozin Sale Price by Company (2018-2023) & (US$/G)
Table 20. Key Manufacturers Oxaprozin Producing Area Distribution and Sales Area
Table 21. Players Oxaprozin Products Offered
Table 22. Oxaprozin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oxaprozin Sales by Geographic Region (2018-2023) & (KG)
Table 26. Global Oxaprozin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Oxaprozin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Oxaprozin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Oxaprozin Sales by Country/Region (2018-2023) & (KG)
Table 30. Global Oxaprozin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Oxaprozin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Oxaprozin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Oxaprozin Sales by Country (2018-2023) & (KG)
Table 34. Americas Oxaprozin Sales Market Share by Country (2018-2023)
Table 35. Americas Oxaprozin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Oxaprozin Revenue Market Share by Country (2018-2023)
Table 37. Americas Oxaprozin Sales by Type (2018-2023) & (KG)
Table 38. Americas Oxaprozin Sales by Application (2018-2023) & (KG)
Table 39. APAC Oxaprozin Sales by Region (2018-2023) & (KG)
Table 40. APAC Oxaprozin Sales Market Share by Region (2018-2023)
Table 41. APAC Oxaprozin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Oxaprozin Revenue Market Share by Region (2018-2023)
Table 43. APAC Oxaprozin Sales by Type (2018-2023) & (KG)
Table 44. APAC Oxaprozin Sales by Application (2018-2023) & (KG)
Table 45. Europe Oxaprozin Sales by Country (2018-2023) & (KG)
Table 46. Europe Oxaprozin Sales Market Share by Country (2018-2023)
Table 47. Europe Oxaprozin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Oxaprozin Revenue Market Share by Country (2018-2023)
Table 49. Europe Oxaprozin Sales by Type (2018-2023) & (KG)
Table 50. Europe Oxaprozin Sales by Application (2018-2023) & (KG)
Table 51. Middle East & Africa Oxaprozin Sales by Country (2018-2023) & (KG)
Table 52. Middle East & Africa Oxaprozin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Oxaprozin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Oxaprozin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Oxaprozin Sales by Type (2018-2023) & (KG)
Table 56. Middle East & Africa Oxaprozin Sales by Application (2018-2023) & (KG)
Table 57. Key Market Drivers & Growth Opportunities of Oxaprozin
Table 58. Key Market Challenges & Risks of Oxaprozin
Table 59. Key Industry Trends of Oxaprozin
Table 60. Oxaprozin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Oxaprozin Distributors List
Table 63. Oxaprozin Customer List
Table 64. Global Oxaprozin Sales Forecast by Region (2024-2029) & (KG)
Table 65. Global Oxaprozin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Oxaprozin Sales Forecast by Country (2024-2029) & (KG)
Table 67. Americas Oxaprozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Oxaprozin Sales Forecast by Region (2024-2029) & (KG)
Table 69. APAC Oxaprozin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Oxaprozin Sales Forecast by Country (2024-2029) & (KG)
Table 71. Europe Oxaprozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Oxaprozin Sales Forecast by Country (2024-2029) & (KG)
Table 73. Middle East & Africa Oxaprozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Oxaprozin Sales Forecast by Type (2024-2029) & (KG)
Table 75. Global Oxaprozin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Oxaprozin Sales Forecast by Application (2024-2029) & (KG)
Table 77. Global Oxaprozin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Oxaprozin Product Portfolios and Specifications
Table 80. Pfizer Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Helsinn Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 84. Helsinn Oxaprozin Product Portfolios and Specifications
Table 85. Helsinn Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 86. Helsinn Main Business
Table 87. Helsinn Latest Developments
Table 88. Taisho Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 89. Taisho Oxaprozin Product Portfolios and Specifications
Table 90. Taisho Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 91. Taisho Main Business
Table 92. Taisho Latest Developments
Table 93. Ildong Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 94. Ildong Oxaprozin Product Portfolios and Specifications
Table 95. Ildong Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 96. Ildong Main Business
Table 97. Ildong Latest Developments
Table 98. PD-Rx Pharmaceuticals Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 99. PD-Rx Pharmaceuticals Oxaprozin Product Portfolios and Specifications
Table 100. PD-Rx Pharmaceuticals Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 101. PD-Rx Pharmaceuticals Main Business
Table 102. PD-Rx Pharmaceuticals Latest Developments
Table 103. Therapicon Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 104. Therapicon Oxaprozin Product Portfolios and Specifications
Table 105. Therapicon Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 106. Therapicon Main Business
Table 107. Therapicon Latest Developments
Table 108. Neolpharma Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 109. Neolpharma Oxaprozin Product Portfolios and Specifications
Table 110. Neolpharma Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 111. Neolpharma Main Business
Table 112. Neolpharma Latest Developments
Table 113. Apotex Corporation Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 114. Apotex Corporation Oxaprozin Product Portfolios and Specifications
Table 115. Apotex Corporation Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 116. Apotex Corporation Main Business
Table 117. Apotex Corporation Latest Developments
Table 118. Yichang Dongyangguang Changjiang Pharmaceutical Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 119. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product Portfolios and Specifications
Table 120. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 121. Yichang Dongyangguang Changjiang Pharmaceutical Main Business
Table 122. Yichang Dongyangguang Changjiang Pharmaceutical Latest Developments
Table 123. Hubei Baike Hengdi Pharmaceutical Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 124. Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolios and Specifications
Table 125. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 126. Hubei Baike Hengdi Pharmaceutical Main Business
Table 127. Hubei Baike Hengdi Pharmaceutical Latest Developments
Table 128. Fuan Pharmaceutical Group Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 129. Fuan Pharmaceutical Group Oxaprozin Product Portfolios and Specifications
Table 130. Fuan Pharmaceutical Group Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 131. Fuan Pharmaceutical Group Main Business
Table 132. Fuan Pharmaceutical Group Latest Developments
Table 133. Hubei Baike Hengdi Pharmaceutical Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 134. Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolios and Specifications
Table 135. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 136. Hubei Baike Hengdi Pharmaceutical Main Business
Table 137. Hubei Baike Hengdi Pharmaceutical Latest Developments
Table 138. Pfizer Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 139. Pfizer Oxaprozin Product Portfolios and Specifications
Table 140. Pfizer Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 141. Pfizer Main Business
Table 142. Pfizer Latest Developments
Table 1. Oxaprozin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oxaprozin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsule
Table 5. Global Oxaprozin Sales by Type (2018-2023) & (KG)
Table 6. Global Oxaprozin Sales Market Share by Type (2018-2023)
Table 7. Global Oxaprozin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Oxaprozin Revenue Market Share by Type (2018-2023)
Table 9. Global Oxaprozin Sale Price by Type (2018-2023) & (US$/G)
Table 10. Global Oxaprozin Sales by Application (2018-2023) & (KG)
Table 11. Global Oxaprozin Sales Market Share by Application (2018-2023)
Table 12. Global Oxaprozin Revenue by Application (2018-2023)
Table 13. Global Oxaprozin Revenue Market Share by Application (2018-2023)
Table 14. Global Oxaprozin Sale Price by Application (2018-2023) & (US$/G)
Table 15. Global Oxaprozin Sales by Company (2018-2023) & (KG)
Table 16. Global Oxaprozin Sales Market Share by Company (2018-2023)
Table 17. Global Oxaprozin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Oxaprozin Revenue Market Share by Company (2018-2023)
Table 19. Global Oxaprozin Sale Price by Company (2018-2023) & (US$/G)
Table 20. Key Manufacturers Oxaprozin Producing Area Distribution and Sales Area
Table 21. Players Oxaprozin Products Offered
Table 22. Oxaprozin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oxaprozin Sales by Geographic Region (2018-2023) & (KG)
Table 26. Global Oxaprozin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Oxaprozin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Oxaprozin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Oxaprozin Sales by Country/Region (2018-2023) & (KG)
Table 30. Global Oxaprozin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Oxaprozin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Oxaprozin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Oxaprozin Sales by Country (2018-2023) & (KG)
Table 34. Americas Oxaprozin Sales Market Share by Country (2018-2023)
Table 35. Americas Oxaprozin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Oxaprozin Revenue Market Share by Country (2018-2023)
Table 37. Americas Oxaprozin Sales by Type (2018-2023) & (KG)
Table 38. Americas Oxaprozin Sales by Application (2018-2023) & (KG)
Table 39. APAC Oxaprozin Sales by Region (2018-2023) & (KG)
Table 40. APAC Oxaprozin Sales Market Share by Region (2018-2023)
Table 41. APAC Oxaprozin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Oxaprozin Revenue Market Share by Region (2018-2023)
Table 43. APAC Oxaprozin Sales by Type (2018-2023) & (KG)
Table 44. APAC Oxaprozin Sales by Application (2018-2023) & (KG)
Table 45. Europe Oxaprozin Sales by Country (2018-2023) & (KG)
Table 46. Europe Oxaprozin Sales Market Share by Country (2018-2023)
Table 47. Europe Oxaprozin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Oxaprozin Revenue Market Share by Country (2018-2023)
Table 49. Europe Oxaprozin Sales by Type (2018-2023) & (KG)
Table 50. Europe Oxaprozin Sales by Application (2018-2023) & (KG)
Table 51. Middle East & Africa Oxaprozin Sales by Country (2018-2023) & (KG)
Table 52. Middle East & Africa Oxaprozin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Oxaprozin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Oxaprozin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Oxaprozin Sales by Type (2018-2023) & (KG)
Table 56. Middle East & Africa Oxaprozin Sales by Application (2018-2023) & (KG)
Table 57. Key Market Drivers & Growth Opportunities of Oxaprozin
Table 58. Key Market Challenges & Risks of Oxaprozin
Table 59. Key Industry Trends of Oxaprozin
Table 60. Oxaprozin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Oxaprozin Distributors List
Table 63. Oxaprozin Customer List
Table 64. Global Oxaprozin Sales Forecast by Region (2024-2029) & (KG)
Table 65. Global Oxaprozin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Oxaprozin Sales Forecast by Country (2024-2029) & (KG)
Table 67. Americas Oxaprozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Oxaprozin Sales Forecast by Region (2024-2029) & (KG)
Table 69. APAC Oxaprozin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Oxaprozin Sales Forecast by Country (2024-2029) & (KG)
Table 71. Europe Oxaprozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Oxaprozin Sales Forecast by Country (2024-2029) & (KG)
Table 73. Middle East & Africa Oxaprozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Oxaprozin Sales Forecast by Type (2024-2029) & (KG)
Table 75. Global Oxaprozin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Oxaprozin Sales Forecast by Application (2024-2029) & (KG)
Table 77. Global Oxaprozin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Oxaprozin Product Portfolios and Specifications
Table 80. Pfizer Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Helsinn Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 84. Helsinn Oxaprozin Product Portfolios and Specifications
Table 85. Helsinn Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 86. Helsinn Main Business
Table 87. Helsinn Latest Developments
Table 88. Taisho Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 89. Taisho Oxaprozin Product Portfolios and Specifications
Table 90. Taisho Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 91. Taisho Main Business
Table 92. Taisho Latest Developments
Table 93. Ildong Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 94. Ildong Oxaprozin Product Portfolios and Specifications
Table 95. Ildong Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 96. Ildong Main Business
Table 97. Ildong Latest Developments
Table 98. PD-Rx Pharmaceuticals Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 99. PD-Rx Pharmaceuticals Oxaprozin Product Portfolios and Specifications
Table 100. PD-Rx Pharmaceuticals Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 101. PD-Rx Pharmaceuticals Main Business
Table 102. PD-Rx Pharmaceuticals Latest Developments
Table 103. Therapicon Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 104. Therapicon Oxaprozin Product Portfolios and Specifications
Table 105. Therapicon Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 106. Therapicon Main Business
Table 107. Therapicon Latest Developments
Table 108. Neolpharma Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 109. Neolpharma Oxaprozin Product Portfolios and Specifications
Table 110. Neolpharma Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 111. Neolpharma Main Business
Table 112. Neolpharma Latest Developments
Table 113. Apotex Corporation Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 114. Apotex Corporation Oxaprozin Product Portfolios and Specifications
Table 115. Apotex Corporation Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 116. Apotex Corporation Main Business
Table 117. Apotex Corporation Latest Developments
Table 118. Yichang Dongyangguang Changjiang Pharmaceutical Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 119. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product Portfolios and Specifications
Table 120. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 121. Yichang Dongyangguang Changjiang Pharmaceutical Main Business
Table 122. Yichang Dongyangguang Changjiang Pharmaceutical Latest Developments
Table 123. Hubei Baike Hengdi Pharmaceutical Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 124. Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolios and Specifications
Table 125. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 126. Hubei Baike Hengdi Pharmaceutical Main Business
Table 127. Hubei Baike Hengdi Pharmaceutical Latest Developments
Table 128. Fuan Pharmaceutical Group Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 129. Fuan Pharmaceutical Group Oxaprozin Product Portfolios and Specifications
Table 130. Fuan Pharmaceutical Group Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 131. Fuan Pharmaceutical Group Main Business
Table 132. Fuan Pharmaceutical Group Latest Developments
Table 133. Hubei Baike Hengdi Pharmaceutical Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 134. Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolios and Specifications
Table 135. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 136. Hubei Baike Hengdi Pharmaceutical Main Business
Table 137. Hubei Baike Hengdi Pharmaceutical Latest Developments
Table 138. Pfizer Basic Information, Oxaprozin Manufacturing Base, Sales Area and Its Competitors
Table 139. Pfizer Oxaprozin Product Portfolios and Specifications
Table 140. Pfizer Oxaprozin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 141. Pfizer Main Business
Table 142. Pfizer Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oxaprozin
Figure 2. Oxaprozin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oxaprozin Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Oxaprozin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oxaprozin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsule
Figure 11. Global Oxaprozin Sales Market Share by Type in 2022
Figure 12. Global Oxaprozin Revenue Market Share by Type (2018-2023)
Figure 13. Oxaprozin Consumed in Rheumatoid Arthritis
Figure 14. Global Oxaprozin Market: Rheumatoid Arthritis (2018-2023) & (KG)
Figure 15. Oxaprozin Consumed in Chronic Infectious Arthritis
Figure 16. Global Oxaprozin Market: Chronic Infectious Arthritis (2018-2023) & (KG)
Figure 17. Oxaprozin Consumed in Osteoarthritis
Figure 18. Global Oxaprozin Market: Osteoarthritis (2018-2023) & (KG)
Figure 19. Oxaprozin Consumed in Ankylosing Spondylitis
Figure 20. Global Oxaprozin Market: Ankylosing Spondylitis (2018-2023) & (KG)
Figure 21. Oxaprozin Consumed in Neck Shoulder Wrist Syndrome
Figure 22. Global Oxaprozin Market: Neck Shoulder Wrist Syndrome (2018-2023) & (KG)
Figure 23. Oxaprozin Consumed in Periarthritis Of Shoulder
Figure 24. Global Oxaprozin Market: Periarthritis Of Shoulder (2018-2023) & (KG)
Figure 25. Oxaprozin Consumed in Gout
Figure 26. Global Oxaprozin Market: Gout (2018-2023) & (KG)
Figure 27. Oxaprozin Consumed in Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
Figure 28. Global Oxaprozin Market: Anti-Inflammatory and Analgesic Effects After Trauma and Surgery (2018-2023) & (KG)
Figure 29. Oxaprozin Consumed in Other
Figure 30. Global Oxaprozin Market: Other (2018-2023) & (KG)
Figure 31. Global Oxaprozin Sales Market Share by Application (2022)
Figure 32. Global Oxaprozin Revenue Market Share by Application in 2022
Figure 33. Oxaprozin Sales Market by Company in 2022 (KG)
Figure 34. Global Oxaprozin Sales Market Share by Company in 2022
Figure 35. Oxaprozin Revenue Market by Company in 2022 ($ Million)
Figure 36. Global Oxaprozin Revenue Market Share by Company in 2022
Figure 37. Global Oxaprozin Sales Market Share by Geographic Region (2018-2023)
Figure 38. Global Oxaprozin Revenue Market Share by Geographic Region in 2022
Figure 39. Americas Oxaprozin Sales 2018-2023 (KG)
Figure 40. Americas Oxaprozin Revenue 2018-2023 ($ Millions)
Figure 41. APAC Oxaprozin Sales 2018-2023 (KG)
Figure 42. APAC Oxaprozin Revenue 2018-2023 ($ Millions)
Figure 43. Europe Oxaprozin Sales 2018-2023 (KG)
Figure 44. Europe Oxaprozin Revenue 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Oxaprozin Sales 2018-2023 (KG)
Figure 46. Middle East & Africa Oxaprozin Revenue 2018-2023 ($ Millions)
Figure 47. Americas Oxaprozin Sales Market Share by Country in 2022
Figure 48. Americas Oxaprozin Revenue Market Share by Country in 2022
Figure 49. Americas Oxaprozin Sales Market Share by Type (2018-2023)
Figure 50. Americas Oxaprozin Sales Market Share by Application (2018-2023)
Figure 51. United States Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Canada Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 53. Mexico Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 54. Brazil Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 55. APAC Oxaprozin Sales Market Share by Region in 2022
Figure 56. APAC Oxaprozin Revenue Market Share by Regions in 2022
Figure 57. APAC Oxaprozin Sales Market Share by Type (2018-2023)
Figure 58. APAC Oxaprozin Sales Market Share by Application (2018-2023)
Figure 59. China Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 60. Japan Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 61. South Korea Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Southeast Asia Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 63. India Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 64. Australia Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 65. China Taiwan Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 66. Europe Oxaprozin Sales Market Share by Country in 2022
Figure 67. Europe Oxaprozin Revenue Market Share by Country in 2022
Figure 68. Europe Oxaprozin Sales Market Share by Type (2018-2023)
Figure 69. Europe Oxaprozin Sales Market Share by Application (2018-2023)
Figure 70. Germany Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 71. France Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 72. UK Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 73. Italy Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 74. Russia Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 75. Middle East & Africa Oxaprozin Sales Market Share by Country in 2022
Figure 76. Middle East & Africa Oxaprozin Revenue Market Share by Country in 2022
Figure 77. Middle East & Africa Oxaprozin Sales Market Share by Type (2018-2023)
Figure 78. Middle East & Africa Oxaprozin Sales Market Share by Application (2018-2023)
Figure 79. Egypt Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 80. South Africa Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 81. Israel Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 82. Turkey Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 83. GCC Country Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 84. Manufacturing Cost Structure Analysis of Oxaprozin in 2022
Figure 85. Manufacturing Process Analysis of Oxaprozin
Figure 86. Industry Chain Structure of Oxaprozin
Figure 87. Channels of Distribution
Figure 88. Global Oxaprozin Sales Market Forecast by Region (2024-2029)
Figure 89. Global Oxaprozin Revenue Market Share Forecast by Region (2024-2029)
Figure 90. Global Oxaprozin Sales Market Share Forecast by Type (2024-2029)
Figure 91. Global Oxaprozin Revenue Market Share Forecast by Type (2024-2029)
Figure 92. Global Oxaprozin Sales Market Share Forecast by Application (2024-2029)
Figure 93. Global Oxaprozin Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Oxaprozin
Figure 2. Oxaprozin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oxaprozin Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Oxaprozin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oxaprozin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsule
Figure 11. Global Oxaprozin Sales Market Share by Type in 2022
Figure 12. Global Oxaprozin Revenue Market Share by Type (2018-2023)
Figure 13. Oxaprozin Consumed in Rheumatoid Arthritis
Figure 14. Global Oxaprozin Market: Rheumatoid Arthritis (2018-2023) & (KG)
Figure 15. Oxaprozin Consumed in Chronic Infectious Arthritis
Figure 16. Global Oxaprozin Market: Chronic Infectious Arthritis (2018-2023) & (KG)
Figure 17. Oxaprozin Consumed in Osteoarthritis
Figure 18. Global Oxaprozin Market: Osteoarthritis (2018-2023) & (KG)
Figure 19. Oxaprozin Consumed in Ankylosing Spondylitis
Figure 20. Global Oxaprozin Market: Ankylosing Spondylitis (2018-2023) & (KG)
Figure 21. Oxaprozin Consumed in Neck Shoulder Wrist Syndrome
Figure 22. Global Oxaprozin Market: Neck Shoulder Wrist Syndrome (2018-2023) & (KG)
Figure 23. Oxaprozin Consumed in Periarthritis Of Shoulder
Figure 24. Global Oxaprozin Market: Periarthritis Of Shoulder (2018-2023) & (KG)
Figure 25. Oxaprozin Consumed in Gout
Figure 26. Global Oxaprozin Market: Gout (2018-2023) & (KG)
Figure 27. Oxaprozin Consumed in Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
Figure 28. Global Oxaprozin Market: Anti-Inflammatory and Analgesic Effects After Trauma and Surgery (2018-2023) & (KG)
Figure 29. Oxaprozin Consumed in Other
Figure 30. Global Oxaprozin Market: Other (2018-2023) & (KG)
Figure 31. Global Oxaprozin Sales Market Share by Application (2022)
Figure 32. Global Oxaprozin Revenue Market Share by Application in 2022
Figure 33. Oxaprozin Sales Market by Company in 2022 (KG)
Figure 34. Global Oxaprozin Sales Market Share by Company in 2022
Figure 35. Oxaprozin Revenue Market by Company in 2022 ($ Million)
Figure 36. Global Oxaprozin Revenue Market Share by Company in 2022
Figure 37. Global Oxaprozin Sales Market Share by Geographic Region (2018-2023)
Figure 38. Global Oxaprozin Revenue Market Share by Geographic Region in 2022
Figure 39. Americas Oxaprozin Sales 2018-2023 (KG)
Figure 40. Americas Oxaprozin Revenue 2018-2023 ($ Millions)
Figure 41. APAC Oxaprozin Sales 2018-2023 (KG)
Figure 42. APAC Oxaprozin Revenue 2018-2023 ($ Millions)
Figure 43. Europe Oxaprozin Sales 2018-2023 (KG)
Figure 44. Europe Oxaprozin Revenue 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Oxaprozin Sales 2018-2023 (KG)
Figure 46. Middle East & Africa Oxaprozin Revenue 2018-2023 ($ Millions)
Figure 47. Americas Oxaprozin Sales Market Share by Country in 2022
Figure 48. Americas Oxaprozin Revenue Market Share by Country in 2022
Figure 49. Americas Oxaprozin Sales Market Share by Type (2018-2023)
Figure 50. Americas Oxaprozin Sales Market Share by Application (2018-2023)
Figure 51. United States Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Canada Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 53. Mexico Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 54. Brazil Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 55. APAC Oxaprozin Sales Market Share by Region in 2022
Figure 56. APAC Oxaprozin Revenue Market Share by Regions in 2022
Figure 57. APAC Oxaprozin Sales Market Share by Type (2018-2023)
Figure 58. APAC Oxaprozin Sales Market Share by Application (2018-2023)
Figure 59. China Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 60. Japan Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 61. South Korea Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Southeast Asia Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 63. India Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 64. Australia Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 65. China Taiwan Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 66. Europe Oxaprozin Sales Market Share by Country in 2022
Figure 67. Europe Oxaprozin Revenue Market Share by Country in 2022
Figure 68. Europe Oxaprozin Sales Market Share by Type (2018-2023)
Figure 69. Europe Oxaprozin Sales Market Share by Application (2018-2023)
Figure 70. Germany Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 71. France Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 72. UK Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 73. Italy Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 74. Russia Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 75. Middle East & Africa Oxaprozin Sales Market Share by Country in 2022
Figure 76. Middle East & Africa Oxaprozin Revenue Market Share by Country in 2022
Figure 77. Middle East & Africa Oxaprozin Sales Market Share by Type (2018-2023)
Figure 78. Middle East & Africa Oxaprozin Sales Market Share by Application (2018-2023)
Figure 79. Egypt Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 80. South Africa Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 81. Israel Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 82. Turkey Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 83. GCC Country Oxaprozin Revenue Growth 2018-2023 ($ Millions)
Figure 84. Manufacturing Cost Structure Analysis of Oxaprozin in 2022
Figure 85. Manufacturing Process Analysis of Oxaprozin
Figure 86. Industry Chain Structure of Oxaprozin
Figure 87. Channels of Distribution
Figure 88. Global Oxaprozin Sales Market Forecast by Region (2024-2029)
Figure 89. Global Oxaprozin Revenue Market Share Forecast by Region (2024-2029)
Figure 90. Global Oxaprozin Sales Market Share Forecast by Type (2024-2029)
Figure 91. Global Oxaprozin Revenue Market Share Forecast by Type (2024-2029)
Figure 92. Global Oxaprozin Sales Market Share Forecast by Application (2024-2029)
Figure 93. Global Oxaprozin Revenue Market Share Forecast by Application (2024-2029)
